This code system http://hl7.org/fhir/sid/cvx defines many codes, of which the following are a subset:
Code | Display | Definition | V2 Table Status | deprecated | V2 Concept Comment As Published |
54 | adenovirus, type 4 | adenovirus, type 4 | A | 2.9 | adenovirus vaccine, type 4, live, oral |
55 | adenovirus, type 7 | adenovirus, type 7 | A | 2.9 | adenovirus vaccine, type 7, live, oral |
82 | adenovirus, NOS1 | adenovirus, NOS1 | A | 2.9 | adenovirus vaccine, NOS |
24 | anthrax | anthrax | A | 2.9 | anthrax vaccine |
19 | BCG | BCG | A | 2.9 | Bacillus Calmette-Guerin vaccine |
27 | botulinum antitoxin | botulinum antitoxin | A | 2.9 | botulinum antitoxin |
26 | cholera | cholera | A | 2.9 | cholera vaccine |
29 | CMVIG | CMVIG | A | 2.9 | cytomegalovirus immune globulin, intravenous |
56 | dengue fever | dengue fever | A | 2.9 | dengue fever vaccine |
12 | diphtheria antitoxin | diphtheria antitoxin | A | 2.9 | diphtheria antitoxin |
28 | DT (pediatric) | DT (pediatric) | A | 2.9 | diphtheria and tetanus toxoids, adsorbed for pediatric use |
20 | DTaP | DTaP | A | 2.9 | diphtheria, tetanus toxoids and acellular pertussis vaccine |
106 | DTaP, 5 pertussis antigens6 | DTaP, 5 pertussis antigens6 | A | 2.9 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
107 | DTaP, NOS | DTaP, NOS | A | 2.9 | diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS |
110 | DTaP-Hep B-IPV | DTaP-Hep B-IPV | A | 2.9 | DTaP-hepatitis B and poliovirus vaccine |
50 | DTaP-Hib | DTaP-Hib | A | 2.9 | DTaP-Haemophilus influenzae type b conjugate vaccine |
120 | DTaP-Hib-IPV | DTaP-Hib-IPV | A | 2.9 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
01 | DTP | DTP | A | 2.9 | diphtheria, tetanus toxoids and pertussis vaccine |
22 | DTP-Hib | DTP-Hib | A | 2.9 | DTP-Haemophilus influenzae type b conjugate vaccine |
102 | DTP-Hib-Hep B | DTP-Hib-Hep B | A | 2.9 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
57 | hantavirus | hantavirus | A | 2.9 | hantavirus vaccine |
52 | Hep A, adult | Hep A, adult | A | 2.9 | hepatitis A vaccine, adult dosage |
83 | Hep A, ped/adol, 2 dose | Hep A, ped/adol, 2 dose | A | 2.9 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
84 | Hep A, ped/adol, 3 dose | Hep A, ped/adol, 3 dose | A | 2.9 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
31 | Hep A, pediatric, NOS | Hep A, pediatric, NOS | A | 2.9 | hepatitis A vaccine, pediatric dosage, NOS |
85 | Hep A, NOS | Hep A, NOS | A | 2.9 | hepatitis A vaccine, NOS |
104 | Hep A-Hep B | Hep A-Hep B | A | 2.9 | hepatitis A and hepatitis B vaccine |
30 | HBIG | HBIG | A | 2.9 | hepatitis B immune globulin |
08 | Hep B, adolescent or pediatric | Hep B, adolescent or pediatric | A | 2.9 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
42 | Hep B, adolescent/high risk infant2 | Hep B, adolescent/high risk infant2 | A | 2.9 | hepatitis B vaccine, adolescent/high risk infant dosage |
43 | Hep B, adult4 | Hep B, adult4 | A | 2.9 | hepatitis B vaccine, adult dosage |
44 | Hep B, dialysis | Hep B, dialysis | A | 2.9 | hepatitis B vaccine, dialysis patient dosage |
45 | Hep B, NOS | Hep B, NOS | A | 2.9 | hepatitis B vaccine, NOS |
58 | Hep C | Hep C | A | 2.9 | hepatitis C vaccine |
59 | Hep E | Hep E | A | 2.9 | hepatitis E vaccine |
60 | herpes simplex 2 | herpes simplex 2 | A | 2.9 | herpes simplex virus, type 2 vaccine |
46 | Hib (PRP-D) | Hib (PRP-D) | A | 2.9 | Haemophilus influenzae type b vaccine, PRP-D conjugate |
47 | Hib (HbOC) | Hib (HbOC) | A | 2.9 | Haemophilus influenzae type b vaccine, HbOC conjugate |
48 | Hib (PRP-T) | Hib (PRP-T) | A | 2.9 | Haemophilus influenzae type b vaccine, PRP-T conjugate |
49 | Hib (PRP-OMP) | Hib (PRP-OMP) | A | 2.9 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
17 | Hib, NOS | Hib, NOS | A | 2.9 | Haemophilus influenzae type b vaccine, conjugate NOS |
51 | Hib-Hep B | Hib-Hep B | A | 2.9 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
61 | HIV | HIV | A | 2.9 | human immunodeficiency virus vaccine |
118 | HPV, bivalent | HPV, bivalent | A | 2.9 | human papilloma virus vaccine, bivalent |
62 | HPV, quadrivalent | HPV, quadrivalent | A | 2.9 | human papilloma virus vaccine, quadrivalent |
86 | IG | IG | A | 2.9 | immune globulin, intramuscular |
87 | IGIV | IGIV | A | 2.9 | immune globulin, intravenous |
14 | IG, NOS | IG, NOS | A | 2.9 | immune globulin, NOS |
111 | influenza, live, intranasal | influenza, live, intranasal | A | 2.9 | influenza virus vaccine, live, attenuated, for intranasal use |
15 | influenza, split (incl. purified surface antigen) | influenza, split (incl. purified surface antigen) | A | 2.9 | influenza virus vaccine, split virus (incl. purified surface antigen) |
16 | influenza, whole | influenza, whole | A | 2.9 | influenza virus vaccine, whole virus |
88 | influenza, NOS | influenza, NOS | A | 2.9 | influenza virus vaccine, NOS |
10 | IPV | IPV | A | 2.9 | poliovirus vaccine, inactivated |
02 | OPV | OPV | A | 2.9 | poliovirus vaccine, live, oral |
89 | polio, NOS | polio, NOS | A | 2.9 | poliovirus vaccine, NOS |
39 | Japanese encephalitis | Japanese encephalitis | A | 2.9 | Japanese encephalitis vaccine |
63 | Junin virus | Junin virus | A | 2.9 | Junin virus vaccine |
64 | leishmaniasis | leishmaniasis | A | 2.9 | leishmaniasis vaccine |
65 | leprosy | leprosy | A | 2.9 | leprosy vaccine |
66 | Lyme disease | Lyme disease | A | 2.9 | Lyme disease vaccine |
03 | MMR | MMR | A | 2.9 | measles, mumps and rubella virus vaccine |
04 | M/R | M/R | A | 2.9 | measles and rubella virus vaccine |
94 | MMRV | MMRV | A | 2.9 | measles, mumps, rubella, and varicella virus vaccine |
67 | malaria | malaria | A | 2.9 | malaria vaccine |
05 | measles | measles | A | 2.9 | measles virus vaccine |
68 | melanoma | melanoma | A | 2.9 | melanoma vaccine |
32 | meningococcal | meningococcal | A | 2.9 | meningococcal polysaccharide vaccine (MPSV4) |
103 | meningococcal C conjugate | meningococcal C conjugate | A | 2.9 | meningococcal C conjugate vaccine |
114 | meningococcal A,C,Y,W-135 diphtheria conjugate | meningococcal A,C,Y,W-135 diphtheria conjugate | A | 2.9 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4) |
108 | meningococcal, NOS | meningococcal, NOS | A | 2.9 | meningococcal vaccine, NOS |
07 | mumps | mumps | A | 2.9 | mumps virus vaccine |
69 | parainfluenza-3 | parainfluenza-3 | A | 2.9 | parainfluenza-3 virus vaccine |
11 | pertussis | pertussis | A | 2.9 | pertussis vaccine |
23 | plague | plague | A | 2.9 | plague vaccine |
33 | pneumococcal | pneumococcal | A | 2.9 | pneumococcal polysaccharide vaccine |
100 | pneumococcal conjugate | pneumococcal conjugate | A | 2.9 | pneumococcal conjugate vaccine, polyvalent |
109 | pneumococcal, NOS | pneumococcal, NOS | A | 2.9 | pneumococcal vaccine, NOS |
70 | Q fever | Q fever | A | 2.9 | Q fever vaccine |
18 | rabies, intramuscular injection | rabies, intramuscular injection | A | 2.9 | rabies vaccine, for intramuscular injection |
40 | rabies, intradermal injection | rabies, intradermal injection | A | 2.9 | rabies vaccine, for intradermal injection |
90 | rabies, NOS | rabies, NOS | A | 2.9 | rabies vaccine, NOS |
72 | rheumatic fever | rheumatic fever | A | 2.9 | rheumatic fever vaccine |
73 | Rift Valley fever | Rift Valley fever | A | 2.9 | Rift Valley fever vaccine |
34 | RIG | RIG | A | 2.9 | rabies immune globulin |
119 | rotavirus, monovalent | rotavirus, monovalent | A | 2.9 | rotavirus, live, monovalent vaccine |
122 | rotavirus, NOS1 | rotavirus, NOS1 | A | 2.9 | rotavirus vaccine, NOS |
116 | rotavirus, pentavalent | rotavirus, pentavalent | A | 2.9 | rotavirus, live, pentavalent vaccine |
74 | rotavirus, tetravalent | rotavirus, tetravalent | A | 2.9 | rotavirus, live, tetravalent vaccine |
71 | RSV-IGIV | RSV-IGIV | A | 2.9 | respiratory syncytial virus immune globulin, intravenous |
93 | RSV-MAb | RSV-MAb | A | 2.9 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
06 | rubella | rubella | A | 2.9 | rubella virus vaccine |
38 | rubella/mumps | rubella/mumps | A | 2.9 | rubella and mumps virus vaccine |
76 | Staphylococcus bacterio lysate | Staphylococcus bacterio lysate | A | 2.9 | Staphylococcus bacteriophage lysate |
113 | Td (adult) | Td (adult) | A | 2.9 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use |
09 | Td (adult) | Td (adult) | A | 2.9 | tetanus and diphtheria toxoids, adsorbed for adult use |
115 | Tdap | Tdap | A | 2.9 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
35 | tetanus toxoid | tetanus toxoid | A | 2.9 | tetanus toxoid, adsorbed |
112 | tetanus toxoid, NOS | tetanus toxoid, NOS | A | 2.9 | tetanus toxoid, NOS |
77 | tick-borne encephalitis | tick-borne encephalitis | A | 2.9 | tick-borne encephalitis vaccine |
13 | TIG | TIG | A | 2.9 | tetanus immune globulin |
95 | TST-OT tine test | TST-OT tine test | A | 2.9 | tuberculin skin test; old tuberculin, multipuncture device |
96 | TST-PPD intradermal | TST-PPD intradermal | A | 2.9 | tuberculin skin test; purified protein derivative solution, intradermal |
97 | TST-PPD tine test | TST-PPD tine test | A | 2.9 | tuberculin skin test; purified protein derivative, multipuncture device |
98 | TST, NOS | TST, NOS | A | 2.9 | tuberculin skin test; NOS |
78 | tularemia vaccine | tularemia vaccine | A | 2.9 | tularemia vaccine |
91 | typhoid, NOS | typhoid, NOS | A | 2.9 | typhoid vaccine, NOS |
25 | typhoid, oral | typhoid, oral | A | 2.9 | typhoid vaccine, live, oral |
41 | typhoid, parenteral | typhoid, parenteral | A | 2.9 | typhoid vaccine, parenteral, other than acetone-killed, dried |
53 | typhoid, parenteral, AKD (U.S. military) | typhoid, parenteral, AKD (U.S. military) | A | 2.9 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
101 | typhoid, ViCPs | typhoid, ViCPs | A | 2.9 | typhoid Vi capsular polysaccharide vaccine |
75 | vaccinia (smallpox) | vaccinia (smallpox) | A | 2.9 | vaccinia (smallpox) vaccine |
105 | vaccinia (smallpox) diluted | vaccinia (smallpox) diluted | A | 2.9 | vaccinia (smallpox) vaccine, diluted |
79 | vaccinia immune globulin | vaccinia immune globulin | A | 2.9 | vaccinia immune globulin |
21 | varicella | varicella | A | 2.9 | varicella virus vaccine |
81 | VEE, inactivated | VEE, inactivated | A | 2.9 | Venezuelan equine encephalitis, inactivated |
80 | VEE, live | VEE, live | A | 2.9 | Venezuelan equine encephalitis, live, attenuated |
92 | VEE, NOS | VEE, NOS | A | 2.9 | Venezuelan equine encephalitis vaccine, NOS |
36 | VZIG | VZIG | A | 2.9 | varicella zoster immune globulin |
117 | VZIG (IND) | VZIG (IND) | A | 2.9 | varicella zoster immune globulin (Investigational New Drug) |
37 | yellow fever | yellow fever | A | 2.9 | yellow fever vaccine |
121 | zoster | zoster | A | 2.9 | zoster vaccine, live |
998 | no vaccine administered5 | no vaccine administered5 | A | 2.9 | no vaccine administered |
999 | unknown | unknown | A | 2.9 | unknown vaccine or immune globulin |
99 | RESERVED - do not use3 | RESERVED - do not use3 | A | 2.9 | RESERVED - do not use |